Cast Your Vote: MedEsthetics 2025 Readers’ Choice Awards Are Now Open!

Jul 28th, 2025
Vote now for MedEsthetics' 2025 Readers' Choice Awards!
Vote now for MedEsthetics' 2025 Readers' Choice Awards!

Voting is now open for the MedEsthetics 2025 Readers’ Choice Awards! Thank you to everyone who submitted nominations—your input helped shape this year’s finalists. Now it’s time to cast your vote and recognize the standout products, brands, and innovations shaping the future of medical aesthetics.

To vote in the MedEsthetics Readers' Choice Awards, simply visit Allured's voting site and select your favorite 2025 devices and skincare products that highlight innovative technology and deliver lasting results. Voting will remain open until Friday, Sept. 12 at 5 p.m. 

Please note that for categories with only one nomination, winners will still be determined based on a minimum number of votes as set by the MedEsthetics team—these single entries are not guaranteed to win. This gives all brands in other categories the fair advantage and same standards to become a finalist. 

Finalists for the Reader’s Choice Categories will be announced the week of Sept. 15. Happy voting and thank you for joining MedEsthetics’ first Readers’ Choice Awards. 

We look forward to seeing you again next year, and many more brands in the years ahead!


 

More in Companies
Allergan Aesthetics seeks FDA approval of Skinvive by Juvéderm for the neck.
Allergan Aesthetics Seeks FDA Approval to Expand Skinvive by Juvéderm for Neck Rejuvenation
Allergan Aesthetics submitted a PMA for the use of Skinvive by Juvéderm for the neck. The application was accepted by the FDA for review, and if approved, the injectable will be used for the appearance of neck lines.
Jul 18th, 2025
3 Training Programs That Offer Hands-On Botox Practice You Should Know About
Sponsored
3 Training Programs That Offer Hands-On Botox Practice You Should Know About
Medical professionals looking to expand their skill set require proper training. Aside from a strong foundational knowledge, an in-person class can boost your confidence and practical experience. 
Jun 18th, 2025
Shed’s new product line for hair loss, Hair Solutions Vertical.
Shed's Dual Hair Care Line Tackles DHT, Hormonal Imbalance, Follicle Health
Shed’s new product line, Hair Solutions Vertical, targets the biological and hormonal processes men and women uniquely experience affecting the hair follicle and growth phase.
Jul 14th, 2025
Treat Medspa opened its flagship location on July 1. Its treatments, personalized using AI-led 3D imaging face and neck assessment technology, will integrate wellness therapies that target neurological factors.
Inside Treat Medspa's NYC Flagship Location: AI Imaging and Brain Science Personalize Beauty at a Cellular Level
Treat Medspa opened its flagship location in Manhattan, New York on July 1. Personalized reatments will use AI-led 3D imaging and wellness therapies that target neurological factors to enhance beauty on an intrinsic level, reflected externally.
Jul 2nd, 2025
Learn how top aesthetic practices use digital marketing, social media, and AI to attract and convert patients in today's competitive landscape with Cutera.
Boost Patient Acquisition Through AI, Social Media, Visual Storytelling with Cutera’s Marketing Experts
Learn how digital marketing tools—from Google Ads to AI platforms like ChatGPT—are revolutionizing how practices attract and retain patients.
Jun 30th, 2025
GLO30 reported a 120% surge in growth, per a May 2025 Kline + Company study, pointing to the fact that membership programs and franchising is becoming a successful direction for businesses in the skin care industry.
Subscription Skincare and Tech-Enabled Wellness Fuel Growth in Facial Studios, Led by GLO30’s Franchise Boom
While franchising has extended GLO30's services, the studio’s packages and membership model treat wellness as a recurring ritual rather than a destination for one-and-done luxurious treatments, generating consistent foot traffic.
Jun 27th, 2025
Ma Logo Black
Merz Aesthetics - Ultherapy
Jun 25th, 2025
Aaams Lead Image
3 Training Programs That Offer Hands-On Botox Practice You Should Know About
Medical professionals looking to expand their skill set require proper training. Aside from a strong foundational knowledge, an in-person class can boost your confidence and practical experience. Discover which training programs offer hands-on Botox
Jun 10th, 2025
Financing options increases accessibility to services and treatments, and allows patients from diverse economic backgrounds to access effective treatments that would normally be out of reach.
Making Medical Aesthetics Accessible with Patient-centered Financing
It is becoming increasingly important for practices to create packages and treatment plans that reflect the market and consumer budgets.
May 20th, 2025
The Neo Elite’s 650-microsecond 1064nm Nd:YAG laser penetrates deeply to treat acne at multiple levels.
The New Era of Acne Management: Clearer Skin, Trusted Devices, Proven Results
Neo® and Era® devices — clinically proven to treat active acne, eliminate causative factors, and address the lasting effects of pigmentation and scarring.
May 19th, 2025
AI-09 is a novel liquid comprised of a botulinum nanoemulsion–an active botulinum molecule encapsulated in a “nano-sized” droplet of oil for the treatment of glabellar lines.
Eirion Therapeutics Unveils Promising AI-09 Liquid Botulinum Trial Results at 2025 SID Meeting
At the 2025 annual meeting of the Society for Investigative Dermatology that took place in San Diego, California on May 7-10, Eirion Therapeutics Inc., a biopharmaceutical company, presented results from recent clinical trials evaluating its AI-09.
May 19th, 2025
Letybo is a 900KD botulinum toxin A produced through enzyme free purification process using a protamine sulfate precipitation, double chromatography, designed to remove nucleic acids and enzymes of animal origin.
With FDA Approval, K-Beauty Letybo Brings High-Purity Botulinum Toxin A to U.S. Injectable Market
Letybo, a common injectable for glabellar lines in South Korea, was approved by the FDA in 2024 and is now finding its way in U.S. practices as a leading neurotoxin next to alternatives like Botox, Dysport and Xeomin.
May 15th, 2025